Nano-X Imaging (NNOX) Income from Continuing Operations (2019 - 2026)
Nano-X Imaging (NNOX) posted quarterly Income from Continuing Operations of 14113000.0 for Q1 2026, down 5.23% year-on-year from 14892551.97 in Q1 2025, and up 61.61% on a QoQ basis from 36761000.0 in Q4 2025.
Nano-X Imaging (NNOX) Income from Continuing Operations (2019 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Income from Continuing Operations for 8 consecutive years, with 14113000.0 the latest figure, recorded in Q1 2026.
- Quarterly Income from Continuing Operations fell 5.23% year-over-year to 14113000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 79304000.0 (down 43.63% YoY) and the FY2025 annual result came in at 27274000.0, down 86.71% from the prior year.
- Income from Continuing Operations climbed to 14113000.0 in Q1 2026 per NNOX's latest filing, from 36761000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for NNOX reached as high as 10406000.0 in Q4 2023 and fell as low as 54901000.0 in Q4 2022.
- A 5-year average of 19352941.18 and a median of 14249000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations soared 81.05% — and 2025, when it sank 157.99%.
- Year by year, Income from Continuing Operations stood at 54901000.0 in 2022, then surged by 81.05% to 10406000.0 in 2023, then tumbled by 36.93% to 14249000.0 in 2024, then plunged by 157.99% to 36761000.0 in 2025, then surged by 61.61% to 14113000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 14113000.0, 36761000.0, and 13872000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | -14.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.11 Mn |
| Dec 31, 2025 | -36.76 Mn |
| Sep 30, 2025 | -13.87 Mn |
| Jun 30, 2025 | -14.56 Mn |
| Mar 31, 2025 | -13.41 Mn |
| Dec 31, 2024 | -14.25 Mn |
| Sep 30, 2024 | -13.83 Mn |
| Jun 30, 2024 | -13.73 Mn |
| Mar 31, 2024 | -12.43 Mn |
| Dec 31, 2023 | -10.41 Mn |
| Sep 30, 2023 | -21.56 Mn |
| Jun 30, 2023 | -17.54 Mn |
| Mar 31, 2023 | -11.95 Mn |
| Dec 31, 2022 | -54.90 Mn |
| Sep 30, 2022 | -19.92 Mn |
| Jun 30, 2022 | -23.81 Mn |
| Mar 31, 2022 | -21.97 Mn |
| Dec 31, 2021 | -22.08 Mn |
| Sep 30, 2021 | -13.47 Mn |
| Jun 30, 2021 | -13.58 Mn |